FreeLIMS’ New Version Empowers Labs to Better Manage Data & Enhance Efficiency

San Francisco, California – FreeLIMS.org announces the release of a new version of its free, secure, configurable, in the cloud LIMS - FreeLIMS. The new version includes a range of new features and enhancements to better cater to the data management and operational needs of biobanks, clinical, research, and analytical testing laboratories, such as cannabis, food [...]

SINGULAR GENOMICS AND BROAD INSTITUTE PARTNER TO INTEGRATE ADVANCED SEQUENCING TECHNOLOGY WITH THE TERRA DATA PLATFORM

THIS PARTNERSHIP WILL HELP BIOMEDICAL RESEARCHERS ACCESS AND ANALYZE DATA FROM SINGULAR GENOMICS SYSTEMS AND EASILY COLLABORATE ON THE CLOUD USING A SECURE, SCALABLE AND OPEN SOURCE INFORMATIC PLATFORM LA JOLLA, Calif. -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today [...]

High-throughput, 384-well Plate-based Solution for Plant DNA Isolation

NORCROSS, GA. Omega Bio-tek, a leading nucleic acid purification kit manufacturer, announces its new plant genomic DNA purification kit, the E-Z 384 Plant DNA HT Kit. The new 384-well silica filter plate-based kit is capable of isolating genomic DNA from up to 768 samples in 1.5 hours when processing two plates in parallel. This kit [...]

RareCyte® Inc. reports significant 2021 growth of Precision Biology™ Services business and customer uptake of Orion™ Spatial Biology instruments and reagents

SEATTLE -- RareCyte Inc., ("RareCyte" or "The Company") a leading provider of Precision Biology products and services recognized over 100% sales growth in their Services business in 2021. They also saw significant uptake by early adopters of their Orion instruments and consumables by global key opinion leaders in support of fast, subcellular whole slide spatial analysis. [...]

Endress+Hauser bundles analysis expertise

Subsidiaries SpectraSensors and Kaiser Optical Systems merge into Endress+Hauser Optical Analysis Effective 1 January 2022, the Endress+Hauser subsidiaries SpectraSensors, Inc. and Kaiser Optical Systems, Inc. have joined forces to form a new company: Endress+Hauser Optical Analysis, Inc. By consolidating its expertise in the field of laser-based measurement technology, the Group is strengthening its focus on [...]

Phase Genomics Advances Precision Oncology with OncoTerra™ a New Ultra-Long-Range Sequencing Powered Platform

SEATTLE -- Phase Genomics, Inc., a biotech company leading advancements in next-generation sequencing (NGS) solutions for genome assembly and analysis, today announced the launch of its new platform for precision oncology. The OncoTerra platform implements a rapid, cost-effective alternative to current cytogenomic analysis tools while unlocking information in even the most challenging of sample types. [...]

Revelar Biotherapeutics and Twist Bioscience Announce RBT-0813 Neutralizes SARS-CoV-2 Omicron (B.1.1.529/BA.1) and Delta (B.1.617.2) Variants

-- Results independently confirmed through live virus plaque-reduction assay -- -- Results published on BioRxiv and submitted to the FDA as part of pre-IND data package -- BETHESDA, Md. & SOUTH SAN FRANCISCO, Calif. -- Revelar Biotherapeutics, Inc. and Twist Bioscience Corporation (Nasdaq: TWST) today announced that RBT-0813 binds to and neutralizes the Omicron and Delta [...]

Berkeley Lights Announces CEO Transition and Preliminary Full Year 2021 Financial Update

Company Provides 2022 Revenue Growth Outlook EMERYVILLE, Calif. -- Berkeley Lights, Inc., (Nasdaq: BLI), (“BLI” or “the Company”), a leader in digital cell biology, today announced that Eric D. Hobbs, Ph.D. will transition from his role as chief executive officer (CEO) and member of the board of directors to president of the Antibody Therapeutics business [...]

Illumina Enters Co-Development Partnership with SomaLogic

Partnership will Accelerate Next-Generation Sequencing into Fastest-Growing Area of Proteomics Market with Ultra-high Throughput, Ultra-high Plexity Workflow SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Proteomics Assay onto Illumina's current and future high throughput next-generation sequencing (NGS) platforms. This partnership [...]

SomaLogic announces exclusive partnership with Illumina to develop sequencing-based proteomic solutions

Co-developed and co-branded products to combine market-leading proteomic and genomic analysis platforms BOULDER, Colo. -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration with Illumina, a global next-generation sequencing technology leader. The multi-year partnership agreement will bring together genomics and proteomics technology platforms in a major commercial partnership [...]

Access IBO on Knowledge Center